Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ablation vs Antiarrhythmic Drugs for VT in Ischemic Cardiomyopathy
NCT03734562Completed
- Sponsor
- Gregorio Marañón University General Hospital
- Start
- Jul 2010
- Primary completion
- Sep 2017
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Gregorio Marañón University General Hospital. Primary endpoints: Occurrence of death from cardiovascular causes at 2 years, Occurrence of appropriate shocks for VT/VF at 2 years and 3 more. Started Jul 2010; status: completed.
Beyond the preview
Go deeper on NCT03734562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03734562.